Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes
- Resource Type
- Article
- Source
- In
Annals of Diagnostic Pathology October 2020 48 - Subject
- Language
- ISSN
- 1092-9134